HTI-1: The New Reality for AI in Healthcare Investment

The whole regulatory world for healthcare AI just got turned upside down. The ONC’s new HTI-1 Final Rule (Health Data, Technology, and Interoperability: Certification Program Updates, Algorithm Transparency, and Information Sharing) is a monster development. This isn’t some minor patch. It fundamentally re-architects how predictive algorithms in certified health IT get developed, deployed, and scrutinized, creating immediate, serious work for health IT developers, compliance attorneys, and the VCs who fund them. The days of opaque, black-box AI in healthcare are over, and a new requirement for radical transparency is here.

The Dawn of Decision Support Intervention (DSI) Transparency

At the center of HTI-1’s new world for algorithm developers is the mandate for Decision Support Intervention (DSI) transparency. The rule goes right after predictive algorithms in certified health IT, demanding a level of disclosure we’ve never seen before. It’s about revealing what an algorithm does, how it works, what data it was trained on, and what its known limitations are. It’s clear the ONC wants to arm clinicians and patients with the information they need to critically evaluate and safely use these AI-driven insights. The compliance deadlines are staggered, but don’t let that fool you, the pressure is on right now. Starting December 31, 2024, health IT modules certified to the 2015 Edition Cures Update have to meet specific DSI transparency criteria, which includes details on the algorithm’s purpose, its development data, and any known biases. Developers have to update their certified tech by that Dec 31, 2024 deadline and then start the ongoing maintenance of certification requirements on January 1, 2025. More granular requirements are coming, phasing in through 2026, things like adopting USCDI Version 3 as the new baseline standard by January 1, 2026, and kicking off Insights Condition reporting on that same date. If you’re a developer and you don’t proactively build these transparency mechanisms into your product lifecycle, you’re risking your market access and inviting serious regulatory trouble. Federal Register notice on HTI-1 final rule

Strategic Implications for Product Development and Regulatory Reporting

Health IT developers have to fundamentally rethink their product development lifecycles and regulatory reporting because of the HTI-1 rule. Big players like Epic Systems and Oracle Health, whose platforms are woven into the fabric of healthcare and use tons of predictive algorithms, now have to conduct massive internal audits to find every single DSI in their certified software. This is a huge undertaking. It means creating detailed documentation of algorithm design, data sources, validation methods, and performance metrics. But the transparency requirements go way beyond just technical specs. How are you going to explain this complex algorithmic info to different groups, from clinicians to patients to regulators? You’ll need to cover, at a minimum:

• Intended Use and Clinical Impact: You must define the exact clinical problem the algorithm is supposed to solve and what its expected effect on patient care will be.
• Data Governance and Training Data: Detail the characteristics of the training and validation data, including demographics, where the data came from, and any data you excluded. This is the only way to spot potential biases and figure out if the algorithm will even work elsewhere.
• Model Performance and Limitations: Give them the numbers, accuracy, precision, recall, and other performance indicators, and then have a frank discussion about the algorithm’s limits, its edge cases, and how it’s known to fail.
• Risk Management and Mitigation: Describe your process for monitoring algorithmic drift and managing the risks that come with using the DSI.

This level of detail is miles beyond traditional software documentation. It forces a culture of constant transparency across the algorithm’s entire life, from the first sketch to post-market surveillance.

Investor Due Diligence and Market Access in the New Era

Venture capital investors, who are obsessed with de-risking their bets, now have to make HTI-1 compliance a central part of their due diligence. The investment case for a healthcare AI company is going to increasingly depend on proving they have a solid, proactive plan for DSI transparency. Any company that didn’t build its AI with transparency in mind from the start is now carrying a huge “regulatory debt” that could crush its valuation and exit multiples. A major question for investors will be how a company is handling the potential for algorithmic drift. The ONC’s focus on transparency creates an expectation of continuous monitoring and re-validation, especially for algorithms that are designed to learn and adapt over time. This lines up perfectly with the broader GMLP (Good Machine Learning Practice) principles that regulators are pushing worldwide, which demand strong quality management systems (think QMS / ISO 13485) that cover the entire AI lifecycle. Even the most amazing technology can fail in a regulated market if it doesn’t have a clear strategy for continuous monitoring and transparent performance reporting. Being able to clearly explain your DSI’s transparency profile is going to be a real competitive advantage. Health systems, buried under their own compliance work, are going to choose certified health IT vendors who can give them this information without a fight. This means established companies like Epic Systems and Oracle Health have to adapt quickly to hold their lead, while new players have a golden opportunity to build transparency into their DNA from day one.

Methodology and Source Note

This analysis is based on our review of the ONC HTI-1 final rule text published in the Federal Register. The opinions here are our editorial team’s assessment of what the rule means, directly and indirectly, for health IT developers and the whole healthcare AI space. Our view is shaped by constantly monitoring federal register notices on health IT certification and related press releases from the Department of Health and Human Services (HHS). ONC HTI-1 fact sheet HHS press release on HTI-1 The HTI-1 rule is a foundational change, mandating transparency for predictive algorithms in healthcare. Developers who get ahead of this by building strong transparency into their product design and regulatory reporting will achieve compliance and, more importantly, build trust with clinicians, patients, and investors. The market will favor those who can prove their AI is not just effective, but also explainable and ethically governed. You need to start dealing with these new requirements now.